WebAbout Bird Rock Bio, Inc. Bird Rock Bio is a clinical stage biotech company focused on developing innovative immuno-inflammatory regulators. WebApr 3, 2024 · Bird Rock Bio, Inc. ClinicalTrials.gov Identifier: NCT03900325 Other Study ID Numbers: BRB-018-200DG : First Posted: April 3, 2024 Key Record Dates: Last Update …
Bird Rock Bio
WebMay 28, 2024 · Bird Rock Bio, Inc., a clinical stage biopharmaceutical company, announced today that the Company has filed an investigational new drug (IND) application with the U.S. Food and Drug Administration (FDA) for the initiation of a phase 2 clinical study of nimacimab, also known as RYI-018, in patients with one of the following renal dis WebFeb 8, 2024 · LA JOLLA, Calif.—In late 2016, Bird Rock Bio Inc., a clinical-stage biopharmaceutical company, reported that it had received approval to start a two-part Phase 1 clinical trial for namacizumab, a therapeutic antibody to the cannabinoid 1 (CB1) receptor.The company has also entered into an agreement with GE Healthcare for … chillax with hemp
Bird Rock Bio Completes Clinical Trial of Nimacimab in Patients …
WebOct 24, 2024 · Akero Therapeutics Inc., Cambridge, Mass. Jennie Walters GS-0976, ndi-010976 Amgen Inc. Atlas Venture Jecure Therapeutics Inc. Versant Partners Inc. Bird Rock Bio Inc. Nimbus... Read More BioCentury Jun 25, 2024 WebMr. Saad is currently a Partner and Chief Operating Officer of Alethea Capital Management, LLC, an asset management firm based in San Diego. Between August 2014 and February 2024 he served as the Chief Financial Officer of Bird Rock Bio, Inc., a clinical stage biopharmaceutical company focused on developing innovative immuno-inflammatory … WebBird Rock Bio, formerly RuiYi, is a clinical stage biopharmaceutical company focused on developing immuno-inflammatory regulators. Use the CB Insights Platform to explore Bird Rock Bio's full profile. grace church olmsted falls